TZBD is incorporated under the laws of the PRC and is headquartered in Tianjin, China. TZBD engages in the business of producing and distributing Reconstituted Bone Xenograft (“RBX”), which is considered to be a medical device. This bone grafting technology accelerates bone healing. Its medical devices are distributed to approximately 400 hospitals in 22 provinces throughout China. TZBD markets its technology to hospitals in China and targets to position itself as a comprehensive medical device provider of bone grafting products and services.
As of the last 10-K on 7/12/2006, there was the following insider ownership:
Name/Title No. of Shares % of ownership
Fuzhi Song, CEO, President and Director 13,170,152 73.8%
Deshun Song 1,463,348 8.2%
Mr Fuzhi Song and Mr Deshun Song are father and son.